Pancreatic cancer breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Neoplastic Stem Cells Mammary Glands, Human Axilla Pancreas Lymph Nodes Epithelial Cells Nipples Neoplastic Cells, Circulating Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases47

Breast Neoplasms Pancreatic Neoplasms Carcinoma, Ductal, Breast Neoplasm Invasiveness Carcinoma, Pancreatic Ductal Neoplasm Metastasis Breast Diseases Adenocarcinoma Genetic Predisposition to Disease Ovarian Neoplasms Carcinoma Breast Neoplasms, Male Lung Neoplasms Disease Progression Prostatic Neoplasms Neoplasms Carcinoma, Lobular Neoplasm Recurrence, Local Colonic Neoplasms Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Stomach Neoplasms Neoplasms, Hormone-Dependent Cell Transformation, Neoplastic Lymphatic Metastasis Bone Neoplasms Carcinoma in Situ Neovascularization, Pathologic Fibrocystic Breast Disease Uterine Cervical Neoplasms Carcinoma, Ductal Colorectal Neoplasms Neoplasms, Second Primary Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Precancerous Conditions Liver Neoplasms Endometrial Neoplasms Neoplastic Cells, Circulating Triple Negative Breast Neoplasms Neoplasms, Radiation-Induced Inflammatory Breast Neoplasms Pancreatitis Disease Models, Animal Rectal Neoplasms Neoplasms, Multiple Primary

Chemicals and Drugs64

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Receptors, Estrogen Epidermal Growth Factor Tumor Markers, Biological Tamoxifen Antineoplastic Agents Receptors, Progesterone Deoxycytidine Neoplasm Proteins Antineoplastic Agents, Hormonal RNA, Messenger RNA, Small Interfering Antimetabolites, Antineoplastic Fluorouracil Estrogen Receptor alpha Estrogens DNA, Neoplasm BRCA2 Protein BRCA1 Protein Cancer Vaccines Antibodies, Monoclonal CA-19-9 Antigen Antibodies, Monoclonal, Humanized Tumor Suppressor Protein p53 Estrogen Antagonists Aromatase Inhibitors Antigens, Neoplasm Tumor Suppressor Proteins RNA, Neoplasm Quinazolines MicroRNAs Paclitaxel Estradiol Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Anticarcinogenic Agents Estrogen Receptor Modulators Nitriles Mucin-1 Cyclophosphamide Transcription Factors Epirubicin DNA-Binding Proteins Ki-67 Antigen Cisplatin Selective Estrogen Receptor Modulators Protein Kinase Inhibitors Antineoplastic Agents, Phytogenic Antigens, CD24 Antibiotics, Antineoplastic Protein-Serine-Threonine Kinases Nuclear Proteins Cadherins Oncogene Proteins v-erbB Cyclin D1 Antigens, Tumor-Associated, Carbohydrate DNA Primers Phosphatidylinositol 3-Kinases Enzyme Inhibitors Prostate-Specific Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Early Detection of Cancer Prognosis Mammography Neoplasm Staging Risk Factors Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Survival Rate Immunohistochemistry Gene Expression Profiling Mastectomy Risk Disease-Free Survival Follow-Up Studies Blotting, Western Prospective Studies Neoplasm Transplantation Retrospective Studies Case-Control Studies Risk Assessment Transplantation, Heterologous Odds Ratio Mammary Neoplasms, Experimental Treatment Outcome Tumor Burden Incidence Combined Modality Therapy Registries Oligonucleotide Array Sequence Analysis Breast Self-Examination Multivariate Analysis Sensitivity and Specificity Kaplan-Meier Estimate Cohort Studies Tissue Array Analysis Transfection SEER Program Questionnaires Mastectomy, Segmental Predictive Value of Tests Polymerase Chain Reaction Drug Screening Assays, Antitumor Logistic Models Immunoenzyme Techniques Molecular Targeted Therapy Reproducibility of Results Clinical Trials as Topic Gene Knockdown Techniques Radiotherapy, Adjuvant Confidence Intervals Neoplasm Grading Drug Administration Schedule Radiotherapy Models, Biological Ultrasonography, Mammary DNA Mutational Analysis Genetic Testing Flow Cytometry Biopsy In Situ Hybridization, Fluorescence Disease Models, Animal Proportional Hazards Models Palliative Care Neoadjuvant Therapy Biopsy, Needle Lymph Node Excision Breast Implants Real-Time Polymerase Chain Reaction

Psychiatry and Psychology3

Breast Self-Examination Breast Feeding Smoking

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Genes, erbB Cell Proliferation Drug Resistance, Neoplasm Genetic Predisposition to Disease Genes, BRCA1 Risk Signal Transduction Apoptosis Postmenopause Mutation Genes, erbB-2 Odds Ratio Cell Movement Premenopause Genes, BRCA2 Cell Growth Processes Cell Division Down-Regulation Menopause Breast Feeding Sensitivity and Specificity Cell Survival RNA Interference Time Factors Transfection Genotype Up-Regulation Cell Cycle Dose-Response Relationship, Drug Germ-Line Mutation DNA Methylation Phosphorylation Promoter Regions, Genetic Gene Silencing Polymorphism, Genetic Gene Amplification Epithelial-Mesenchymal Transition Gene Expression Genes, Neoplasm Drug Synergism Genes, Tumor Suppressor Base Sequence Phenotype Genes, p53 Diet Genes, ras Alleles Tumor Microenvironment Parity Transcription, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care31

Risk Factors Survival Analysis Survival Rate Risk Disease-Free Survival Follow-Up Studies Prospective Studies Retrospective Studies Case-Control Studies Risk Assessment Odds Ratio Treatment Outcome Age Factors Incidence Registries Multivariate Analysis Sensitivity and Specificity Kaplan-Meier Estimate Cohort Studies SEER Program Questionnaires Predictive Value of Tests Logistic Models Reproducibility of Results Clinical Trials as Topic Confidence Intervals National Cancer Institute (U.S.)Genetic Testing Proportional Hazards Models Palliative Care Parity

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Neoplasms Neuregulin-1 Neuregulins Receptor, erbB-3 Pancreatic Neoplasms Receptor, erbB-2 Receptor, Epidermal Growth Factor Breast Cell Line, Tumor Gene Expression Regulation, Neoplastic Receptors, Estrogen Carcinoma, Ductal, Breast Epidermal Growth Factor Neoplasm Invasiveness Carcinoma, Pancreatic Ductal Neoplasm Metastasis Genes, erbB Early Detection of Cancer Mice, Nude Tumor Markers, Biological Prognosis Tamoxifen Antineoplastic Agents Breast Diseases Receptors, Progesterone Mammography Deoxycytidine Neoplasm Proteins Adenocarcinoma Cell Proliferation Neoplasm Staging Risk Factors Drug Resistance, Neoplasm Antineoplastic Combined Chemotherapy Protocols Tumor Cells, Cultured Xenograft Model Antitumor Assays Survival Analysis Genetic Predisposition to Disease Ovarian Neoplasms Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Agents, Hormonal Chemotherapy, Adjuvant Carcinoma Genes, BRCA1 Breast Neoplasms, Male Survival Rate RNA, Messenger Immunohistochemistry Lung Neoplasms Gene Expression Profiling Disease Progression Prostatic Neoplasms Neoplasms Mastectomy Risk Signal Transduction Apoptosis Disease-Free Survival Follow-Up Studies Postmenopause Blotting, Western Prospective Studies Neoplasm Transplantation RNA, Small Interfering Carcinoma, Lobular Retrospective Studies Case-Control Studies Antimetabolites, Antineoplastic MCF-7 Cells Neoplasm Recurrence, Local Colonic Neoplasms Risk Assessment Mutation Carcinoma, Intraductal, Noninfiltrating Genes, erbB-2 Fluorouracil Transplantation, Heterologous Odds Ratio Mammary Neoplasms, Experimental Stomach Neoplasms Cell Movement Neoplasms, Hormone-Dependent Estrogen Receptor alpha Estrogens DNA, Neoplasm BRCA2 Protein Treatment Outcome Age Factors Premenopause Survivors Genes, BRCA2 Tumor Burden Cell Growth Processes Cell Transformation, Neoplastic Cell Division United States Incidence Combined Modality Therapy Down-Regulation Registries

No FAQ available that match "pancreatic cancer breast cancers receptor erbb 2"